Tatiana V Macfarlane1, Tanja Wirth2, Sriyani Ranasinghe3, Kim W Ah-See4, Nick Renny5, David Hurman6. 1. School of Medicine and Dentistry, University of Aberdeen, Aberdeen United Kingdom. 2. School of Medicine and Dentistry, University of Aberdeen, Aberdeen United Kingdom. ; University of Bremen, Bremen Germany. 3. School of Medicine and Dentistry, University of Aberdeen, Aberdeen United Kingdom. ; Postgraduate Institute of Medicine, University of Colombo Sri Lanka. 4. Department of Otolaryngology, Aberdeen Royal Infirmary, Aberdeen United Kingdom. 5. Department of Maxillofacial Surgery, Aberdeen Royal Infirmary, Aberdeen United Kingdom. 6. Department of Clinical Oncology, Aberdeen Royal Infirmary, Aberdeen United Kingdom.
Abstract
OBJECTIVES: Pain is a major symptom in patients with cancer; however information on head and neck cancer related pain is limited. The aim of this review was to investigate the prevalence of pain and associated factors among patients with HNC. MATERIAL AND METHODS: The systematic review used search of MEDLINE, EMBASE and CINAHL databases to December 2011. Cancers of the oral mucosa, oropharynx, hypopharynx and larynx were included in this review with pain as main outcome. The review was restricted to full research reports of observational studies published in English. A checklist was used to assess the quality of selected studies. RESULTS: There were 82 studies included in the review and most of them (84%) were conducted in the past ten years. Studies were relatively small, with a median of 80 patients (IQR 44, 154). The quality of reporting was variable. Most studies (77%) used self-administered quality of life questionnaires, where pain was a component of the overall scale. Only 33 studies reported pain prevalence in HNC patients (combined estimate from meta-analysis before (57%, 95% CI 43% - 70%) and after (42%, 95% CI 33% - 50%) treatment. Only 49 studies (60%) considered associated factors, mostly tumour- or treatment-related. CONCLUSIONS: The study has shown high levels of pain prevalence and some factors associated with higher levels of pain. There is a need for higher quality studies in a priority area for the care of patients with head and neck cancer.
OBJECTIVES:Pain is a major symptom in patients with cancer; however information on head and neck cancer related pain is limited. The aim of this review was to investigate the prevalence of pain and associated factors among patients with HNC. MATERIAL AND METHODS: The systematic review used search of MEDLINE, EMBASE and CINAHL databases to December 2011. Cancers of the oral mucosa, oropharynx, hypopharynx and larynx were included in this review with pain as main outcome. The review was restricted to full research reports of observational studies published in English. A checklist was used to assess the quality of selected studies. RESULTS: There were 82 studies included in the review and most of them (84%) were conducted in the past ten years. Studies were relatively small, with a median of 80 patients (IQR 44, 154). The quality of reporting was variable. Most studies (77%) used self-administered quality of life questionnaires, where pain was a component of the overall scale. Only 33 studies reported pain prevalence in HNC patients (combined estimate from meta-analysis before (57%, 95% CI 43% - 70%) and after (42%, 95% CI 33% - 50%) treatment. Only 49 studies (60%) considered associated factors, mostly tumour- or treatment-related. CONCLUSIONS: The study has shown high levels of pain prevalence and some factors associated with higher levels of pain. There is a need for higher quality studies in a priority area for the care of patients with head and neck cancer.
Entities:
Keywords:
cancer; epidemiology; head and neck cancer; pain; prevalence; review.
Authors: Jan P Vandenbroucke; Erik Von Elm; Douglas G Altman; Peter C Gøtzsche; Cynthia D Mulrow; Stuart J Pocock; Charles Poole; James J Schlesselman; Matthias Egger Journal: Gac Sanit Date: 2009-02-26 Impact factor: 2.139
Authors: M H J van den Beuken-van Everdingen; J M de Rijke; A G Kessels; H C Schouten; M van Kleef; J Patijn Journal: Ann Oncol Date: 2007-03-12 Impact factor: 32.976
Authors: Simon N Rogers; John Devine; Derek Lowe; Parminder Shokar; James S Brown; E David Vaugman Journal: Head Neck Date: 2004-01 Impact factor: 3.147
Authors: Carrie A Karvonen-Gutierrez; David L Ronis; Karen E Fowler; Jeffrey E Terrell; Stephen B Gruber; Sonia A Duffy Journal: J Clin Oncol Date: 2008-06-01 Impact factor: 44.544
Authors: Philippe Lambin; Bram L T Ramaekers; Ghislaine A P G van Mastrigt; P Van den Ende; J de Jong; Dirk K M De Ruysscher; Madelon Pijls-Johannesma Journal: Cochrane Database Syst Rev Date: 2009-07-08
Authors: Patrick B Trotter; Lindsey A Norton; Ann S Loo; Jonathan I Munn; Elena Voge; Kim W Ah-See; Tatiana V Macfarlane Journal: J Oral Maxillofac Res Date: 2013-01-01
Authors: Thales Salles Angelim Viana; Paulo Goberlânio de Barros Silva; Karuza Maria Alves Pereira; Mario Rogério Lima Mota; Ana Paula Negreiros Nunes Alves; Eric Fernandes de Souza; Fabricio Bitu Sousa Journal: Asian Pac J Cancer Prev Date: 2017-08-27